Poolbeg Pharma (POLB) Insider Trading & Ownership → Tiny AI projects with huge promise hiding in plain sight … (From Weiss Ratings) (Ad) Free POLB Stock Alerts GBX 12.70 -0.45 (-3.42%) (As of 02:42 PM ET) Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades Poolbeg Pharma (LON:POLB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.66%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)£116,624.04Number OfInsiders Selling(Last 12 Months)0 Get POLB Insider Trade Alerts Want to know when executives and insiders are buying or selling Poolbeg Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address POLB Insider Buying and Selling by Quarter Ad Banyan Hill PublishingForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadThe AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.Get the full story here. Poolbeg Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/21/2024Jeremy SkillingtonInsiderBuy154,764GBX 11£17,024.042/19/2024Cathal FrielInsiderBuy830,000GBX 12£99,600 (Data available from 1/1/2013 forward) POLB Insider Trading Activity - Frequently Asked Questions Who is on Poolbeg Pharma's Insider Roster? The list of insiders at Poolbeg Pharma includes Cathal Friel, and Jeremy Skillington. Learn more on insiders at POLB. What percentage of Poolbeg Pharma stock is owned by insiders? 22.66% of Poolbeg Pharma stock is owned by insiders. Learn more on POLB's insider holdings. Which Poolbeg Pharma insiders have been buying company stock? The following insiders have purchased POLB shares in the last 24 months: Cathal Friel (£99,600), and Jeremy Skillington (£52,960.69). How much insider buying is happening at Poolbeg Pharma? Insiders have purchased a total of 1,703,497 POLB shares in the last 24 months for a total of £152,560.69 bought. More Insider Trading Tools from MarketBeat Related Companies: e-therapeutics Insider Ownership Sareum Insider Ownership Tissue Regenix Group Insider Ownership Scancell Insider Ownership Oxford BioDynamics Insider Ownership OKYO Pharma Insider Ownership Oncimmune Insider Ownership OptiBiotix Health Insider Ownership 4basebio Insider Ownership Arix Bioscience Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (LON:POLB) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDoes this make you sick?Allegiance Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Poolbeg Pharma PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
